Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
McKesson Corp
(NY:
MCK
)
919.26
-12.09 (-1.30%)
Official Closing Price
Updated: 7:00 PM EST, Mar 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about McKesson Corp
< Previous
1
2
3
4
5
6
7
8
9
...
25
26
Next >
3 Dividend Growth Stocks Quietly Raising Payouts
↗
Today 11:26 EST
Via
MarketBeat
McKesson Corporation Announces Fourth Quarter Fiscal 2026 Earnings Release Date and Participation in Upcoming Conferences
Today 8:00 EST
From
McKesson Corporation
Via
Business Wire
What's going on in today's session: S&P500 movers
↗
March 05, 2026
Via
Chartmill
Thursday's session: gap up and gap down stock in the S&P500 index
↗
March 05, 2026
Via
Chartmill
McKesson Announces Planned CFO Transition
March 05, 2026
From
McKesson Corporation
Via
Business Wire
McKesson Corp (NYSE:MCK) Reports Mixed Q3 2026 Results and Raises Full-Year Profit Outlook
↗
February 04, 2026
Via
Chartmill
McKesson Corp (NYSE:MCK) Fits the 'Affordable Growth' Investment Profile
↗
January 29, 2026
Via
Chartmill
McKesson Corp (NYSE:MCK) Demonstrates Strong Growth and Technical Breakout Potential
↗
January 20, 2026
Via
Chartmill
2 S&P 500 Stocks to Consider Right Now and 1 We Turn Down
March 04, 2026
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor exec...
Via
StockStory
Topics
Stocks
3 Reasons We’re Fans of McKesson (MCK)
March 01, 2026
What a fantastic six months it’s been for McKesson. Shares of the company have skyrocketed 42.9%, setting a new 52-week high of $988.29. This performance may have investors wondering how to approach...
Via
StockStory
Topics
Supply Chain
The Inventory Shield: US Wholesale Data Signals Stability as Markets Brace for New Trade Realities
February 27, 2026
The latest data from the U.S. Census Bureau, released in late February 2026, suggests a surprising degree of resilience within the American supply chain. Wholesale inventories for December 2025 rose by...
Via
MarketMinute
Topics
Economy
Supply Chain
World Trade
3 Market-Beating Stocks for Long-Term Investors
February 19, 2026
The best-performing stocks typically have robust sales growth, increasing margins, and rising returns on capital, and those that can maintain this trifecta year in and year out often become the legends...
Via
StockStory
Topics
Supply Chain
2 Surging Stocks to Own for Decades and 1 We Find Risky
February 16, 2026
Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such as new products and positive media coverage...
Via
StockStory
2 Momentum Stocks Worth Your Attention and 1 We Ignore
February 15, 2026
Each stock in this article is trading near its 52-week high. These elevated prices usually indicate some degree of investor confidence, business improvements, or favorable market conditions.
Via
StockStory
5 Insightful Analyst Questions From McKesson’s Q4 Earnings Call
February 11, 2026
McKesson’s fourth-quarter results met Wall Street’s revenue expectations and modestly exceeded consensus for non-GAAP earnings per share, with the market responding positively. Management attributed...
Via
StockStory
Topics
Artificial Intelligence
Earnings
McKesson (MCK): A Structural Re-rating Driven by Oncology and GLP-1 Momentum
February 06, 2026
McKesson Corporation (NYSE: MCK) stands today as the undisputed titan of the U.S. pharmaceutical supply chain. While the company has long been a staple of the Fortune 500, its relevance has surged in...
Via
Finterra
Topics
Artificial Intelligence
Economy
Fraud
Thursday's session: top gainers and losers in the S&P500 index
↗
February 05, 2026
Via
Chartmill
How the Largest IPO of 2025 Could Be Healthy for Your Portfolio
↗
February 05, 2026
Medline is an appealing investment candidate – it has solid growth, operates in a steady industry, and a storied history.
Via
The Motley Fool
Topics
Economy
Initial Public Offering
MCK Q4 Deep Dive: Oncology, Tech Investments, and Portfolio Focus Drive Growth
February 05, 2026
Healthcare distributor and services company McKesson (NYSE:MCK) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 11.4% year on year to $106.2 billion. Its non-GAAP profit of $9.34 per...
Via
StockStory
McKesson (MCK) Q3 2026 Earnings Call Transcript
↗
February 04, 2026
McKesson (MCK) Q3 2026 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
McKesson (NYSE:MCK) Reports Q4 CY2025 In Line With Expectations
February 04, 2026
Healthcare distributor and services company McKesson (NYSE:MCK) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 11.4% year on year to $106.2 billion. Its non-GAAP profit of $9.34 per...
Via
StockStory
McKesson Corporation Reports Fiscal 2026 Third Quarter Results and Raises Full Year Adjusted EPS Guidance
February 04, 2026
From
McKesson Corporation
Via
Business Wire
Earnings To Watch: McKesson (MCK) Reports Q4 Results Tomorrow
February 02, 2026
Healthcare distributor and services company McKesson (NYSE:MCK) will be announcing earnings results this Wednesday after the bell. Here’s what to expect.
Via
StockStory
McKesson Corporation Completes Divestiture of Norwegian Operations
January 30, 2026
From
McKesson Corporation
Via
Business Wire
McKesson Corporation Declares Quarterly Dividend
January 28, 2026
From
McKesson Corporation
Via
Business Wire
One Fund Bought Up Henry Schein Stock Amid Record Quarterly Results and a New $200 Million Efficiency Plan
↗
December 29, 2025
An improving earnings profile, aggressive buybacks, and a renewed focus on margins might be changing how long-term investors think about this healthcare distributor.
Via
The Motley Fool
Topics
Regulatory Compliance
McKesson Corp (NYSE:MCK): A GARP Stock with Strong Growth at a Reasonable Price
↗
December 26, 2025
McKesson Corp exemplifies GARP investing, offering strong earnings growth at a reasonable valuation within the vital healthcare supply chain.
Via
Chartmill
1 Large-Cap Stock with Impressive Fundamentals and 2 Facing Challenges
December 23, 2025
Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth...
Via
StockStory
3 Big Reasons to Love McKesson (MCK)
December 23, 2025
McKesson trades at $825.38 and has moved in lockstep with the market. Its shares have returned 14.5% over the last six months while the S&P 500 has gained 12.9%.
Via
StockStory
Topics
Stocks
Supply Chain
Citius Oncology Transitions to Commercial Stage: Analyzing the 10-K Filing and the 2026 Outlook for LYMPHIR
December 23, 2025
CRANFORD, NJ — As the 2025 calendar year draws to a close, Citius Oncology, Inc. (Nasdaq: CTOR) has reached a pivotal juncture in its corporate evolution. Following the release of its SEC 10-K filing...
Via
MarketMinute
Topics
Economy
Regulatory Compliance
< Previous
1
2
3
4
5
6
7
8
9
...
25
26
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.